Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed with simplified versus standard folate and dexamethasone supplementation in previously treated advanced non-small cell lung cancer
2007-004950-10Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pemetrexed in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Eli Lilly and Company. Started Nov 2007; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-004950-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004950-10.